Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.52 |
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.52 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | CES2 | O00748 | 1/20 | 0.43 |
| ▸ | CES1 | P23141 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 4/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.42 |
| ▸ | HPGD | P15428 | 3/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.42 |
| ▸ | NPC1 | O15118 | 3/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3075428 | 0.83 | EHMT2 (0.56) | EHMT2EHMT1APOBEC3GALDH1A1KMT2A | |
| SCHEMBL5633792 | 0.83 | EHMT2 (0.56) | EHMT2EHMT1APOBEC3GALDH1A1KMT2A | |
| SCHEMBL1479297 | 0.81 | ALDH1A1 (0.55) | EHMT2EHMT1APOBEC3GALDH1A1KMT2A | |
| SCHEMBL3070731 | 0.79 | EHMT2 (0.52) | EHMT2EHMT1APOBEC3GALDH1A1KMT2A | |
| SCHEMBL4757038 | 0.79 | EHMT2 (0.52) | EHMT2EHMT1APOBEC3GALDH1A1KMT2A | |
| SCHEMBL4483430 | 0.76 | ALDH1A1 (0.54) | EHMT2EHMT1APOBEC3GALDH1A1KMT2A | |
| Bicarbonate SCHEMBL16975005 | 0.75 | ALDH1A1 (0.53) | EHMT2EHMT1APOBEC3GALDH1A1KMT2A | |
| SCHEMBL31289372 | 0.75 | — | — | |
| SCHEMBL1607377 | 0.75 | LMNA (0.51) | EHMT2EHMT1APOBEC3GALDH1A1KMT2A | |
| SCHEMBL14524405 | 0.75 | EHMT2 (0.47) | EHMT2EHMT1APOBEC3GALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12565468-B2 | Processes and intermediates for the preparations of Carboprost and Carboprost Tromethamine, and Carboprost Tromethamine prepared therefrom | CHIROGATE INTERNATIONAL INC. (TW) | 2026-03-03 | — | — | US | disclosed |
| EP-4509492-A2 | PROCESSES AND INTERMEDIATES FOR THE PREPARATIONS OF CARBOPROST AND CARBOPROST TROMETHAMINE, AND CARBOPROST TROMETHAMINE PREPARED THEREFROM | Chirogate International Inc. (TW) | 2025-02-19 | — | — | EP | disclosed |
| US-20230131316-A1 | PROCESSES AND INTERMEDIATES FOR THE PREPARATIONS OF CARBOPROST AND CARBOPROST TROMETHAMINE, AND CARBOPROST TROMETHAMINE PREPARED THEREFROM | CHIROGATE INTERNATIONAL INC. (TW) | 2023-04-27 | — | — | US | disclosed |
| US-20230097470-A1 | PROCESSES AND INTERMEDIATES FOR THE PREPARATIONS OF CARBOPROST AND CARBOPROST TROMETHAMINE, AND CARBOPROST TROMETHAMINE PREPARED THEREFROM | CHIROGATE INTERNATIONAL INC. (TW) | 2023-03-30 | — | — | US | disclosed |
| EP-4140982-A2 | PROCESSES AND INTERMEDIATES FOR THE PREPARATIONS OF CARBOPROST AND CARBOPROST TROMETHAMINE, AND CARBOPROST TROMETHAMINE PREPARED THEREFROM | Chirogate International Inc. (TW) | 2023-03-01 | — | — | EP | disclosed |
| US-10822321-B2 | Processes and intermediates for the preparations of isomer free prostaglandins | CHIROGATE INTERNATIONAL INC. (TW) | 2020-11-03 | — | — | US | disclosed |
| US-20180251442-A1 | PROCESSES AND INTERMEDIATES FOR THE PREPARATIONS OF ISOMER FREE PROSTAGLANDINS | CHIROGATE INTERNATIONAL INC. (TW) | 2018-09-06 | — | — | US | disclosed |
| US-9994543-B2 | Processes and intermediates for the preparations of isomer free prostaglandins | CHIROGATE INTERNATIONAL INC. (TW) | 2018-06-12 | — | — | US | disclosed |
| US-20180050999-A1 | PROCESSES AND INTERMEDIATES FOR THE PREPARATIONS OF ISOMER FREE PROSTAGLANDINS | CHIROGATE INTERNATIONAL INC. (TW) | 2018-02-22 | — | — | US | disclosed |
| US-9890135-B1 | Processes and intermediates for the preparations of isomer free prostaglandins | CHIROGATE INTERNATIONAL INC. (TW) | 2018-02-13 | — | — | US | disclosed |
| US-20040077021-A1 | Derivatives, conjugates, and antibodies for detecting ecstasy-class analytes | ROCHE DIAGNOSTICS CORPORATION | 2004-04-22 | — | — | US | disclosed |
| US-20030175995-A1 | Compounds, antibodies, reagent kits, methods of producing antibodies, and methods of detecting analytes | ROCHE DIAGNOSTICS OPERATIONS, INC. | 2003-09-18 | — | — | US | disclosed |
| US-20030170917-A1 | Compounds, antibodies, reagent kits, methods of producing antibodies, and methods of detecting analytes | ROCHE DIAGNOSTICS CORPORATION | 2003-09-11 | — | — | US | disclosed |
| EP-1340981-A2 | Antibodies for detecting amphetamine derivatives | Roche Diagnostics GmbH (DE) | 2003-09-03 | — | — | EP | disclosed |
| EP-1340980-A1 | Derivatives of amphetamine, antibodies against said derivatives, reagent kits, methods of producing said antibodies, and methods of detecting said derivatives | Roche Diagnostics GmbH (DE) | 2003-09-03 | — | — | EP | disclosed |
| US-6306979-B1 | Derivatized carbon monoxide copolymers | BASF AKTIENGESELLSCHAFT (DE) | 2001-10-23 | — | — | US | disclosed |
| US-5719139-A | BACTERICIDES | ZENECA LIMITED (GB) | 1998-02-17 | — | — | US | disclosed |
| EP-0722945-A1 | 9-oxo-1-azabicyclo(5.2.0)non-2,3-diene-2-carboxylic acid derivatives as antibiotics | ZENECA LIMITED (GB) | 1996-07-24 | — | — | EP | disclosed |
| US-5490980-A | TRANSGLUTAMINASE CROSSLINKS PROTEINS BY CATALYZING THE ACTIVE INGREDIANTS TO GLUTAMINE RESIDUES | CHESEBROUGH-POND'S USA CO., DIVISION OF CONOPCO, INC. (US) | 1996-02-13 | — | — | US | disclosed |
| US-4643991-A | TREATMENT OF EMPHYSEMA | THE UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 1987-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230097470-A1 | PROCESSES AND INTERMEDIATES FOR THE PREPARATIONS OF CARBOPROST AND CARBOPROST TROMETHAMINE, AND CARBOPROST TROMETHAMINE PREPARED THEREFROM | PTGES, PTGES2, PTGIS | EHMT2 2607/4885EHMT1 2760/4885APOBEC3G 1403/4885 |
| US-20180251442-A1 | PROCESSES AND INTERMEDIATES FOR THE PREPARATIONS OF ISOMER FREE PROSTAGLANDINS | PTGER2, PTGES2, PTGER1 | EHMT2 4230/4885EHMT1 4747/4885APOBEC3G 3368/4885 |
| US-20180050999-A1 | PROCESSES AND INTERMEDIATES FOR THE PREPARATIONS OF ISOMER FREE PROSTAGLANDINS | PTGER2, PTGES2, PTGER1 | EHMT2 4230/4885EHMT1 4747/4885APOBEC3G 3368/4885 |
| US-20230131316-A1 | PROCESSES AND INTERMEDIATES FOR THE PREPARATIONS OF CARBOPROST AND CARBOPROST TROMETHAMINE, AND CARBOPROST TROMETHAMINE PREPARED THEREFROM | PTGES, PTGES2, PTGIS | EHMT2 2607/4885EHMT1 2760/4885APOBEC3G 1403/4885 |
| US-10822321-B2 | Processes and intermediates for the preparations of isomer free prostaglandins | PTGER2, PTGES2, PTGER1 | EHMT2 4230/4885EHMT1 4747/4885APOBEC3G 3368/4885 |
| US-12565468-B2 | Processes and intermediates for the preparations of Carboprost and Carboprost Tromethamine, and Carboprost Tromethamine prepared therefrom | PGF, PTGIS, PTGS1 | EHMT2 346/4885EHMT1 194/4885APOBEC3G 1483/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.